Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2011
04/27/2011EP2313394A1 Novel tetramethyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
04/27/2011EP2313393A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof
04/27/2011EP2313392A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof
04/27/2011EP2313391A1 Isoquinolinone derivatives as nk3 antagonists
04/27/2011EP2313390A1 Process for the preparation of nicotine-based haptens
04/27/2011EP2313372A1 Aminopyridine kinase inhibitors
04/27/2011EP2313370A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
04/27/2011EP2313096A1 New compounds v
04/27/2011EP2312949A1 N-heterocyclic m1 receptor positive allosteric modulators
04/27/2011EP2312948A1 5-quinolinone and imidazopyridine compounds and use thereof
04/27/2011EP2312946A1 Pyrimidine derivatives for treatment of alzheimer's disease
04/27/2011EP2102199B1 Antibacterial polycyclic urea compounds
04/27/2011EP2090575B1 Processes and intermediates for the preparation of N4-phenyl-quinazoline-4-amine derivatives
04/27/2011EP2084148B1 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives
04/27/2011EP2001862B1 Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
04/27/2011EP1968967B1 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators
04/27/2011EP1824832B1 Aryl-substituted benzimidazole and imidazopyridine ethers as anti-cancer agents
04/27/2011EP1812112B1 Benzodiazepine derivatives as ROCK kinases inhibitors
04/27/2011EP1622879B1 Pyrimidine compounds and pests controlling compositions containing the same
04/27/2011EP1477175B1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
04/27/2011EP1439175B1 Pyrimidine compound and medicinal composition thereof
04/27/2011EP0934307B1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
04/27/2011CN1810802B 3-substituted-4-pyrimidone derivatives
04/27/2011CN102036982A Substituted pyridin-4-yl-methyl sulfonamides as fungicides
04/27/2011CN102036981A Substituted 4-hydroxypyrimidine-5-carboxamides
04/27/2011CN102036964A Tetrahydroisoquinolines as antimalarial agents
04/27/2011CN102036961A Pyridines and pyrazines as inhibitors of PI3K
04/27/2011CN102036958A Compound comprising phenyl pyridine units
04/27/2011CN102036957A Compound comprising phenyl pyridine units
04/27/2011CN102036955A Hydroxamate-based inhibitors of deacetylases b
04/27/2011CN102030917A Azabenzotriazol containing ultraviolet absorber and preparation method thereof
04/27/2011CN102030739A Method for salifying or recrystallization of rupatadine fumarate
04/27/2011CN102030738A Novel imidazole compound, preparation method and use thereof
04/27/2011CN102030737A Clinafloxacin amino derivatives and application thereof
04/27/2011CN101602732B Derivative of acyl thiourea pyridine, method for preparing same and application thereof
04/27/2011CN101591295B Water-soluble benzopyrazolyl quaternary ammonium salt, preparation method thereof and application thereof
04/27/2011CN101284828B Cycloheptapyridine compounds, preparation method thereof, use and pharmaceutical compositions containing the compounds
04/27/2011CN101250181B S-泮托拉唑钠 S- pantoprazole sodium
04/27/2011CN101219985B N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
04/27/2011CN101103020B Cgrp receptor antagonists
04/27/2011CN101033224B Novel pyrimidines small molecular compound, its preparation method and use
04/26/2011US7932401 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant
04/26/2011US7932395 Substituted 1H-dihydropyrazoles, their preparation and use
04/26/2011US7932394 1-{[5-[4-(Methylsulfonyl)phenoxy]-2-(2-pyridinyl)-1H-benzimidazol-6-yl]methyl}-5-thioxo-2-pyrrolidinone;glucokinase activator; antidiabetic agents; obesity; prevention of retinopathy, nephropathy, neurosis, ischemic cardiopathy, arteriosclerosis; antiischemic agents; cardiotonic agents
04/26/2011US7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
04/26/2011US7932281 Amine-based compound and use thereof
04/26/2011US7932273 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament
04/26/2011US7932271 Heterocyclic methyl sulfone derivative
04/26/2011US7932270 Certain chemical entities, compositions, and methods
04/26/2011US7932250 Thienopyrazole derivative having PDE7 inhibitory activity
04/26/2011US7932247 M3 muscarinic acetylcholine receptor antagonists
04/26/2011US7932246 Histone deacetylase inhibitors
04/26/2011CA2634676C Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein cetp
04/26/2011CA2612286C Substituted arylpyrazoles as parasiticidal agents
04/26/2011CA2601458C Benzimidazolone derivatives as cb2 receptor ligands
04/26/2011CA2583742C 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists
04/26/2011CA2508474C Pesticidal sulphonylaminopyrazoles
04/26/2011CA2479133C 2-4-diaminopyrimidine derivatives
04/26/2011CA2477657C Cathepsin cysteine protease inhibitors
04/26/2011CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use
04/26/2011CA2467718C Chemokine receptor binding heterocyclic compounds with enhanced efficacy
04/26/2011CA2462416C Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
04/26/2011CA2460145C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
04/26/2011CA2446461C Substituted cyclohexane-1,4-diamine derivatives
04/26/2011CA2408838C Drug/drug delivery systems for the prevention and treatment of vascular disease
04/26/2011CA2322194C Metal-catalyzed arylations and vinylations of hydrazines, hydrazones, hydroxylamines and oximes
04/21/2011WO2011046997A1 Cgrp receptor antagonists
04/21/2011WO2011046970A1 Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon
04/21/2011WO2011046964A2 Inhibitors of bruton's tyrosine kinase
04/21/2011WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses
04/21/2011WO2011045383A2 2, 6 -diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases
04/21/2011WO2011045292A1 Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes
04/21/2011WO2011045271A1 Herbicidally active, heterocyclyl-substituted pyridazinones
04/21/2011WO2011045259A1 Aminopropenoates as fungicides
04/21/2011WO2011045257A1 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions
04/21/2011WO2011045240A1 Amides and thioamides as pesticides
04/21/2011WO2011045084A1 Quinolinyloxyphenylsulfonamides
04/21/2011WO2011026911A8 Bipyridines useful for the treatment of proliferative diseases
04/21/2011WO2011017347A3 Mesoionic pesticides
04/21/2011WO2010150281A3 Novel azabicyclohexanes
04/21/2011WO2010141600A3 Improved method for synthesizing pirfenidone
04/21/2011WO2010141406A3 Amino pyrimidine anticancer compounds
04/21/2011WO2010120750A3 Amorphous esomeprazole magnesium
04/21/2011WO2010067130A8 P38 map kinase inhibitors
04/21/2011US20110092702 Crystalline antifungal compounds
04/21/2011US20110092700 Novel Coumarin Derivative Having Antitumor Activity
04/21/2011US20110092698 Novel heterocyclyl compounds
04/21/2011US20110092695 Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance
04/21/2011US20110092689 Fluorescence quencher molecules
04/21/2011US20110092553 Substituted Azole Derivatives, Compositions, and Methods of Use
04/21/2011US20110092544 Fungicidal pyridines
04/21/2011US20110092540 Substituted n-phenyl-2,3-dihydroimidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands
04/21/2011US20110092537 2,6-Diaminopyridine Compounds Suitable For Treating Diseases Associated With Amyloid Or Amyloid-Like Proteins Or For Treating Or Preventing Ocular Diseases Or Conditions Associated With A Pathological Abnormality/Change In The Tissue Of The Visual System
04/21/2011US20110092529 1,2,4-Triazole Derivatives and Their Use as Oxytocin Antagonists
04/21/2011US20110092528 Piperidinyl compounds that selectively bind integrins
04/21/2011US20110092516 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressin-dependent diseases
04/21/2011US20110092513 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases
04/21/2011US20110092512 New hsl inhibitors useful in the treatment of diabetes
04/21/2011US20110092505 Organic compounds
04/21/2011US20110092504 Inhibitors of pi3 kinase